A growing body of preclinical research points to the TIE2 receptor and its angiopoietin ligands as a promising drug target for brain blood vessel defects, including arteriovenous malformations, venous ...

In the quiet arithmetic of survival during precarious moments, O-negative blood often arrives before names or consent forms—and that timing makes all the difference. THE WEEK takes you on the life sav ...

A novel implantable biologics device that uses engineered cells to produce multiple therapies inside the body at once shows ...

A 2026 consumer information guide examining ProHealth BPC-157 oral peptide capsule details, arginate vs acetate formulation ...

In the U.S., women outlive men by an average of 6 years, a trend observed across many ethnicities and time periods. This ...

Denali Therapeutics solved a major challenge in Hunter syndrome treatment. Now it's ready to take its technology further.

Researchers developed a soft, conductive hydrogel that binds and releases growth factors via electrical signals, opening new ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the fourth ...

A 2026 report outlining Steel Power ingredient research, male enhancement supplement positioning, performance claim context, ...

Building on the success of GLOW1 and with all patients on a 6-month dosing interval, Zenkuda (tarcocimab tedromer) demonstrated superiority to sham with 62.5% of Zenkuda-treated patients achieving ...

In a large trial, the approved therapy Winrevair showed confirmed benefits for CpcPH-HFpEF, a type of PH associated with ...

The proportion of people in the U.S. with PAH related to methamphetamine use increased by 93% between 2018 and 2022, a study ...